Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 13/20 | 0.54 |
| ▸ | CTSD | P07339 | 1/20 | 0.52 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30259249 | 0.94 | BACE1 (0.60) | BACE1CTSDBACE2 | |
| SCHEMBL30931573 | 0.86 | OPRD1 (0.53) | — | |
| SCHEMBL29398845 | 0.84 | BACE1 (0.69) | BACE1CTSDBACE2 | |
| SCHEMBL10598700 | 0.84 | FNTA (0.56) | — | |
| SCHEMBL30567793 | 0.84 | BACE1 (0.67) | BACE1CTSDBACE2 | |
| SCHEMBL30512736 | 0.83 | TFPI (0.53) | BACE1 | |
| SCHEMBL29457312 | 0.83 | KISS1R (0.50) | BACE1BACE2 | |
| SCHEMBL7953518 | 0.82 | BACE1 (0.49) | BACE1CTSD | |
| SCHEMBL30051567 | 0.82 | MMP8 (0.56) | — | |
| SCHEMBL30262993 | 0.81 | KISS1R (0.55) | BACE1BACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034197-A1 | Peptides and Fragments for Treating Diabetes and Associated Metabolic Diseases | BETAVIVE LTD. (IL) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034197-A1 | Peptides and Fragments for Treating Diabetes and Associated Metabolic Diseases | IAPP, GLP1R, IGF1R | BACE1 126/4885CTSD 736/4885BACE2 88/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.